Lupin Limited
Lupin Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: LUPIN and BSE: 500257 (ISIN INE326A01037).
It has a market capitalisation of ₹88,660 crore, a last close of ₹1,939 on 2026-10-19, a one-year return of -0.0%.
Valuation: a price-to-earnings ratio of 16.04x, a price-to-book ratio of 3.95x, a dividend yield of 0.9%.
Profitability: return on equity of 26.9%, return on capital employed of 31.8%, an operating margin of 31.8%.
Growth: sales growth of 18.9% a year over three years, net profit growth of 131.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.26x, promoter holding of 46.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 88,660 |
| Last close | ₹1,939 |
| P/E (TTM) | 16.04x |
| P/B | 3.95x |
| Dividend yield | 0.9% |
| ROE (FY) | 26.9% |
| ROCE (FY) | 31.8% |
| Operating margin (TTM) | 31.8% |
| Sales growth, 3-year CAGR | 18.9% |
| Profit growth, 3-year CAGR | 131.5% |
| Debt / equity | 0.26x |
| Promoter holding | 46.8% |
| 1-year return | -0.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means